Johnson & Johnson (NYSE:JNJ) -1.9% after-hours following a Philadelphia jury ruling that it must pay $8B billion in punitive damages
to a man who previously won $680K over his claims that it failed to
warn that men using its Risperdal anti-psychotic drug could grow
breasts.
The Philadelphia verdict is the first case in
which a Pennsylvania jury was able to consider awarding punitive damages
in one of thousands of Risperdal cases pending in the state.
https://seekingalpha.com/news/3504615-j-and-j-must-pay-8b-risperdal-case-jury-says
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.